Effect of synthetic and natural phospholipids on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D activity

Chemistry and Physics of Lipids

Volumn 162, Issue 1-2, 2009, Pages 53-61

  Petersen, Gitte ^a   Pedersen, Anders H ^b   Pickering, Darryl S ^a   Begtrup, Mikael ^b   Hansen, Harald S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Anandamide; Cannabinoid; Diether phospholipid substrate; NAPE PLD; Oleoylethanolamide; Palmitoylethanolamide

Indexed keywords

1,2 DIHEXANOYLGLYCERO N [3 (TETRADECANOYLAMINO)PROPYL]PHOSPHORAMIDIC ACID; AHP 17 B; BETA LACTAMASE; NITROCEFIN; ORGANOPHOSPHATE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYNTHESIS;

CELL LINE; CEPHALOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MOLECULAR STRUCTURE; PHOSPHOLIPASE D; PHOSPHOLIPIDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349783689     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2009.08.005     Document Type: Article

References (59)

1. Artmann A., Petersen G., Hellgren L.I., Boberg J., Skonberg C., Nellemann C., Hansen S.H., and Hansen H.S. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta 1781 (2008) 200-212
2. Bebrone C., Moali C., Mahy F., Rival S., Docquier J.D., Rossolini G.M., Fastrez J., Pratt R.F., Frere J.M., and Galleni M. CENTA as a chromogenic substrate for studying beta-lactamases. Antimicrob. Agents Chemother. 45 (2001) 1868-1871
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Carman G.M., Deems R.A., and Dennis E.A. Lipid signaling enzymes and surface dilution kinetics. J. Biol. Chem. 270 (1995) 18711-18714
5. Corey E.J., Cashman J.R., Kantner S.S., and Wright S.W. Rationally designed, potent competitive inhibitors of leukotriene biosynthesis. J. Am. Chem. Soc. 106 (1984) 1503-1504
6. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., and Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9371-9376
7. Darmani N.A., Izzo A.A., Degenhardt B., Valenti M., Scaglione G., Capasso R., Sorrentini I., and Di M.V. Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. Neuropharmacology 48 (2005) 1154-1163
8. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
9. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (1994) 686-691
10. Fu J., Astarita G., Gaetani S., Kim J., Cravatt B.F., Mackie K., and Piomelli D. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J. Biol. Chem. 282 (2007) 1518-1528
11. Giang D.K., and Cravatt B.F. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2238-2242
12. Grzeskowiak K. 2-Cyanoethyl 2,2,2-trichloroethyl phosphorochloridate; an effective reagent for the phosphorylation of nucleosides. Synthesis 1980 (1980) 831-833
13. Guo Y., Wang H., Okamoto Y., Ueda N., Kingsley P.J., Marnett L.J., Schmid H.H., Das S.K., and Dey S.K. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J. Biol. Chem. 280 (2005) 23429-23432
14. Hansen H.S., Moesgaard B., Hansen H.H., and Petersen G. N-acylethanolamines and precursor phospholipids-relation to cell injury. Chem. Phys. Lipids 108 (2000) 135-150
15. Hansen H.S., Moesgaard B., Petersen G., and Hansen H.H. Putative neuroprotective actions of N-acyl-ethanolamines. Pharmacol. Ther. 95 (2002) 119-126
16. Hansen H.S., Petersen G., Artmann A., and Madsen A.N. Endocannabinoids. Eur. J. Lipid Sci. Technol. 108 (2006) 877-889
17. 2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J. Biol. Chem. 282 (2007) 3614-3623
18. Li S., and Eakin R. Synthesis of N-phosphorylated derivatives of amino acids. J. Am. Chem. Soc. 77 (1955) 1866-1870
19. Liu J., Wang L., Harvey-White J., Osei-Hyiaman D., Razdan R., Gong Q., Chan A.C., Zhou Z., Huang B.X., Kim H.Y., and Kunos G. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 13345-13350
20. Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., and Piomelli D. The nuclear receptor PPAR-α mediates the antiinflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67 (2005) 15-19
21. Maccarrone M., Valensise H., Bari M., Lazzarin N., Romanini C., and Finazzi-Agro A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355 (2000) 1326-1329
22. Martin S.F., and Hergenrother P.J. Enzymatic synthesis of a modified phospholipid and its evaluation as a substrate for B. Cereus phospholipase C. Bioorg. Med. Chem. Lett. 8 (1998) 593-596
23. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., and Vogel Z. Identification of en endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
24. 31P NMR and enzyme activity study. J. Lipid Res. 41 (2000) 985-990
25. Movahed P., Jonsson B.A., Birnir B., Wingstrand J.A., Dyhring J.T., Ermund A., Sterner O., Zygmunt P.M., and Hogestatt E.D. Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J. Biol. Chem. 280 (2005) 38496-38504
26. Nielsen M.J., Petersen G., Astrup A., and Hansen H.S. Food intake is inhibited by oral oleoylethanolamide. J. Lipid Res. 45 (2004) 1027-1029
27. O'Sullivan S.E. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br. J. Pharmacol. 152 (2007) 576-582
28. Okamoto Y., Morishita J., Tsuboi K., Tonai T., and Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279 (2004) 5298-5305
29. Okamoto Y., Wang J., Morishita J., and Ueda N. Biosynthetic pathways of the endocannabinoid anandamide. Chem. Biodivers. 4 (2007) 1842-1857
30. Overton H.A., Babbs A.J., Doel S.M., Fyfe M.C., Gardner L.S., Griffin G., Jackson H.C., Procter M.J., Rasamison C.M., Tang-Christensen M., Widdowson P.S., Williams G.M., and Reynet C. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 3 (2006) 167-175
31. Oz M. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol. Ther. 111 (2006) 114-144
32. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58 (2006) 389-462
33. Paria B.C., and Dey S.K. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem. Phys. Lipids 108 (2000) 211-220
34. Paria B.C., Song H., Wang X., Schmid P.C., Krebsbach R.J., Schmid H.H.O., Bonner T.I., Zimmer A., and Dey S.K. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J. Biol. Chem. 276 (2001) 20523-20528
35. Paria B.C., Wang H., and Dey S.K. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. Chem. Phys. Lipids 121 (2002) 201-210
36. Patricelli M.P., and Cravatt B.F. Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides. Vitam. Horm. 62 (2001) 95-131
37. Payne D.J., Cramp R., Bateson J.H., Neale J., and Knowles D. Rapid identification of metallo- and serine beta-lactamases. Antimicrob. Agents Chemother. 38 (1994) 991-996
38. Pedersen D., and Rosenbohm C. Dry column vacuum chromatography. Synthesis (2001) 2431-2434
39. Petersen G., Chapman K.D., and Hansen H.S. A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: application to N-acylethanolamine formation in vitro. J. Lipid Res. 41 (2000) 1532-1538
40. Reichenberg A., Wiesner J., Weidemeyer C., Dreiseidler E., Sanderbrand S., Altincicek B., Beck E., Schlitzer M., and Jomaa H. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg. Med. Chem. Lett. 11 (2001) 833-835
41. Rodriguez de Fonseca F., Navarro M., Gomez R., Escuredo L., Nava F., Fu J., Murillo-Rodriguez E., Giuffrida A., LoVerme J., Gaetani S., Kathuria S., Gall C., and Piomelli D. An anorexic lipid mediator regulated by feeding. Nature 414 (2001) 209-212
42. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., Elebring T., Nilsson K., Drmota T., and Greasley P.J. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 152 (2007) 1092-1101
43. Schmid H.H.O., Schmid P.C., and Natarajan V. N-acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29 (1990) 1-43
44. Shangguan T., Pak C.C., Ali S., Janoff A.S., and Meers P. Cation-dependent fusogenicity of N-acyl phosphatidylethanolamine. Biochim. Biophys. Acta 1368 (1998) 171-183
45. Simon G.M., and Cravatt B.F. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J. Biol. Chem. 281 (2006) 26465-26472
46. Simon G.M., and Cravatt B.F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 283 (2008) 9341-9349
47. Stepinski D., Zalupski A., and Herlinger A. Facile high yielding synthesis of symmetric esters of methylenebisphosphonic acid. Tetrahedron 57 (2000) 8637-8645
48. Sugiura T., Kishimoto S., Oka S., and Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45 (2006) 405-446
49. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., and Ishima Y. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor-structure-activity relationship of 2-arachidonoylglycerol ether-linked analogues, and related compounds. J. Biol. Chem. 274 (1999) 2794-2801
50. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., and Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor-comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275 (2000) 605-612
51. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-Arachidonoylgylcerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215 (1995) 89-97
52. Sun Y.X., Tsuboi K., Okamoto Y., Tonai T., Murakami M., Kudo I., and Ueda N. Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A 2 and lysophospholipase D. Biochem. J. 380 (2004) 749-756
53. Taylor A.H., Ang C., Bell S.C., and Konje J.C. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum. Reprod. Update. 13 (2007) 501-513
54. Tsuboi K., Zhao L.Y., Okamoto Y., Araki N., Ueno M., Sakamoto H., and Ueda N. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies. Biochim. Biophys. Acta 1771 (2007) 623-632
55. Wang H., Matsumoto H., Guo Y., Paria B.C., Roberts R.L., and Dey S.K. Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14914-14919
56. Wang J., Okamoto Y., Tsuboi K., and Ueda N. The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD). Neuropharmacology 54 (2008) 8-15
57. White H.S., Sarup A., Bolvig T., Kristensen A.S., Petersen G., Nelson N., Pickering D.S., Larsson O.M., Frolund B., Krogsgaard-Larsen P., and Schousboe A. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs. J. Pharmacol. Exp. Ther. 302 (2002) 636-644
58. Zeniou-Meyer M., Zabari N., Ashery U., Chasserot-Golaz S., Haeberle A.M., Demais V., Bailly Y., Gottfried I., Nakanishi H., Neiman A.M., Du G., Frohman M.A., Bader M.F., and Vitale N. Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage. J. Biol. Chem. 282 (2007) 21746-21757
59. Zhao C., Du G., Skowronek K., Frohman M.A., and Bar-Sagi D. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Natl. Cell Biol. 9 (2007) 706-712